Clinical Trial Update: Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of nebulized Pulmicort Respules (budesonide) in patients with primary lung cancer and COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Lung Cancer

Drugs mentioned

• Pulmicort Respules (budesonide)

Snippet

Sponsor: Xiuyi Zhi | Conditions: Post Operative Complication, Pulmonary, Lung Cancer | Phase 4 | Status: UNKNOWN